266 related articles for article (PubMed ID: 32205841)
21. LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in gastric cancer.
Wei Y; Zhang F; Zhang T; Zhang Y; Chen H; Wang F; Li Y
Aging (Albany NY); 2019 Oct; 11(20):8951-8968. PubMed ID: 31649207
[TBL] [Abstract][Full Text] [Related]
22. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
Kaida T; Nitta H; Kitano Y; Yamamura K; Arima K; Izumi D; Higashi T; Kurashige J; Imai K; Hayashi H; Iwatsuki M; Ishimoto T; Hashimoto D; Yamashita Y; Chikamoto A; Imanura T; Ishiko T; Beppu T; Baba H
Oncotarget; 2016 Dec; 7(51):84798-84809. PubMed ID: 27756879
[TBL] [Abstract][Full Text] [Related]
23. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
24. TIPE1 suppresses invasion and migration through down-regulating Wnt/β-catenin pathway in gastric cancer.
Liu W; Chen Y; Xie H; Guo Y; Ren D; Li Y; Jing X; Li D; Wang X; Zhao M; Zhu T; Wang Z; Wei X; Gao F; Wang X; Liu S; Zhang Y; Yi F
J Cell Mol Med; 2018 Feb; 22(2):1103-1117. PubMed ID: 28994231
[TBL] [Abstract][Full Text] [Related]
25. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer.
Xia B; Zhang K; Liu C
Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986
[TBL] [Abstract][Full Text] [Related]
26. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
27. Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition.
Ge Q; Hu Y; He J; Chen F; Wu L; Tu X; Qi Y; Zhang Z; Xue M; Chen S; Zhong J; Wang L
FASEB J; 2020 Feb; 34(2):2161-2172. PubMed ID: 31909528
[TBL] [Abstract][Full Text] [Related]
28. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
[TBL] [Abstract][Full Text] [Related]
29. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis.
Lin L; Liu Y; Pan C; Zhang J; Zhao Y; Shao R; Huang Z; Su Y; Shi M; Bin J; Liao Y; Li N; Wang C; Liao W
Theranostics; 2019; 9(7):2100-2114. PubMed ID: 31037159
[TBL] [Abstract][Full Text] [Related]
31. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
[TBL] [Abstract][Full Text] [Related]
32. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
Qin CD; Ma DN; Zhang SZ; Zhang N; Ren ZG; Zhu XD; Jia QA; Chai ZT; Wang CH; Sun HC; Tang ZY
Cell Death Dis; 2018 May; 9(5):486. PubMed ID: 29706627
[TBL] [Abstract][Full Text] [Related]
33. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
[TBL] [Abstract][Full Text] [Related]
34. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
35. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
[TBL] [Abstract][Full Text] [Related]
36. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
[TBL] [Abstract][Full Text] [Related]
37. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
38. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
[TBL] [Abstract][Full Text] [Related]
39. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
40. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
